Bristol-Myers Squibb Company (BMY): Price and Financial Metrics

Bristol-Myers Squibb Company (BMY): $61.27

-0.36 (-0.58%)

POWR Rating

Component Grades













BMY Stock Summary

  • With a market capitalization of $138,080,483,679, Bristol Myers Squibb Co has a greater market value than 98.42% of US stocks.
  • BMY's went public 35.19 years ago, making it older than 92.77% of listed US stocks we're tracking.
  • In terms of volatility of its share price, BMY is more volatile than merely 0.6% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Bristol Myers Squibb Co are SNY, RTX, DE, AMGN, and AZN.
  • BMY's SEC filings can be seen here. And to visit Bristol Myers Squibb Co's official web site, go to

BMY Stock Price Chart Interactive Chart >

Price chart for BMY

BMY Price/Volume Stats

Current price $61.27 52-week high $67.16
Prev. close $61.63 52-week low $45.76
Day low $61.21 Volume 9,584,864
Day high $62.18 Avg. volume 12,951,763
50-day MA $62.27 Dividend yield 3.18%
200-day MA $60.92 Market Cap 137.27B

Bristol-Myers Squibb Company (BMY) Company Bio

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular. The company was founded in 1887 and is based in New York, New York.

BMY Latest News Stream

Event/Time News Detail
Loading, please wait...

BMY Latest Social Stream

Loading social stream, please wait...

View Full BMY Social Stream

Latest BMY News From Around the Web

Below are the latest news stories about Bristol Myers Squibb Co that investors may wish to consider to help them evaluate BMY as an investment opportunity.

The Buzzing Gene-Editing Market Of Crispr Therapeutics

Investment Thesis The promising clinical results of CRISPR Therapeutics' (CRSP) pipeline combined with their blockbuster potential provide an attractive investment proposition for investors wishing to establish a biotech position. CRSP is one of the few companies holding a patent to use CRISPR. This disruptive gene-editing technology helped its discoverers win...

Bashar Issa on Seeking Alpha | March 2, 2021

Hotchkis & Wiley's Top 5 Trades of the 4th Quarter

Changes to top holdings Citigroup and GE

Yahoo | March 1, 2021

Bristol Myers Squibb Announces Dividend

Bristol Myers Squibb Announces Dividend

Yahoo | March 1, 2021

3 Top Stocks That'll Make You Richer in March (and Beyond)

Growth stocks increase their sales by a double-digit percentage, are concerned with gobbling up market share, and aren't too focused on generating a profit. Meanwhile, value stocks are companies that have forward price-to-earnings multiples or price-to-earnings-growth ratios (PEG ratio) below the average of their industry or the broader market.

Yahoo | March 1, 2021

Bristol-Myers Squibb: Undervalued Dividend Contender, Offering Income, Dividend Growth, And Capital Appreciation

Investment Thesis Bristol-Myers Squibb (BMY) is a biopharmaceutical company whose focus is on discovering, developing, and delivering transformational medicines for patients facing serious diseases in areas where they believe that there is an opportunity to make a meaningful difference: oncology (both solid tumors and hematology), immunology, cardiovascular and fibrosis. During...

James Marino on Seeking Alpha | February 28, 2021

Read More 'BMY' Stories Here

BMY Price Returns

1-mo -0.26%
3-mo -0.68%
6-mo 3.62%
1-year 4.77%
3-year 1.53%
5-year 8.82%
YTD -1.23%
2020 0.41%
2019 27.74%
2018 -12.90%
2017 7.71%
2016 -13.49%

BMY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BMY Dividend History

Continue Researching BMY

Here are a few links from around the web to help you further your research on Bristol Myers Squibb Co's stock as an investment opportunity:

Bristol Myers Squibb Co (BMY) Stock Price | Nasdaq
Bristol Myers Squibb Co (BMY) Stock Quote, History and News - Yahoo Finance
Bristol Myers Squibb Co (BMY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8697 seconds.